The Clinical Core with facilities on the two University of Southern California campuses will continue to facilitate ADRC goals related to Alzheimer's disease (AD), aging, and dementia through the recruitment of demented and non-demented elderly control subjects; medical, neuropsychological, and laboratory evaluation; and clinical data analysis. The Clinical Core is essential to the Neuropathology Core to make post-mortem tissues available for basic neurobiological studies.
Specific Aims are (1) to provide well-characterized, longitudinally- assessed AD, non-demented """"""""normal control,"""""""" and other designated subjects for clinical and autopsy research needs of the ADRC; (2) to support ADRC sponsored research on inclusion body myositis and working memory; (3) to maintain through the Pharmacology Program an infrastructure for clinical pharmacological research on AD; (4) to coordinate the use of Clinical Core data and subjects by participating investigators and to catalyze new clinical and basic research projects on AD and related disorders; (5) to contribute to a common Administrative Core research database; and (6) to provide a setting for training and support services for AD patients, caregivers, lay persons, and health care professionals. New control subjects are anticipated from older women in a Permanente Group of Southern California cohort. In years 16-20, the Clinical Core will continue to maintain autopsy requirements for AD and control subjects (with targeted exceptions) and to work closely with other ADRC components in enhancing minority recruitment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005142-16S1
Application #
6295395
Study Section
Project Start
1999-04-01
Project End
2000-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Gahm, Jin Kyu; Shi, Yonggang; Alzheimer’s Disease Neuroimaging Initiative (2018) Riemannian metric optimization on surfaces (RMOS) for intrinsic brain mapping in the Laplace-Beltrami embedding space. Med Image Anal 46:189-201
Emrani, Sheina; Libon, David J; Lamar, Melissa et al. (2018) Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall. J Alzheimers Dis 61:917-928
Hernandez, Gerson; Zhao, Liqin; Franke, Adrian A et al. (2018) Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor ?-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. Menopause 25:191-196
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Ho, Jean K; Nation, Daniel A; Alzheimer’s Disease Neuroimaging Initiative (2018) Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease. J Int Neuropsychol Soc 24:693-702
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 590 publications